Mycobacterium avium subspecies paratuberculosis and Type-2 Diabetes Mellitus
Author Information
Author(s): Rosu Valentina, Ahmed Niyaz, Paccagnini Daniela, Pacifico Adolfo, Zanetti Stefania, Sechi Leonardo A
Primary Institution: Dipartimento di Scienze Biomediche, Sezione di Microbiologia clinica e sperimentale, University of Sassari, Italy
Hypothesis
Does Mycobacterium avium subspecies paratuberculosis (MAP) play a role in Type-2 Diabetes Mellitus (T2DM)?
Conclusion
There is no significant association between MAP and T2DM in Sardinian patients.
Supporting Evidence
- 57 T2DM patients were tested for antibodies against MAP.
- Statistical analysis showed no significant difference in antibody levels between T2DM patients and healthy controls.
- The study used three different MAP antigen preparations for testing.
Takeaway
The study found that people with Type-2 Diabetes do not have higher levels of certain antibodies related to a bacteria called MAP, suggesting it doesn't cause this type of diabetes.
Methodology
The study tested blood samples from 57 T2DM patients and 57 healthy controls for antibodies against MAP using ELISA.
Limitations
The study only included Sardinian patients, which may limit the generalizability of the findings.
Participant Demographics
57 patients with Type-2 Diabetes Mellitus and 57 healthy controls, all confirmed negative for tuberculosis and other autoimmune diseases.
Statistical Information
P-Value
0.9899
Statistical Significance
p>0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website